Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms

Jos Weusten, Marion Vermeulen, Harry van Drimmelen, +1

Transfusion

Sensitivity of individual‐donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis <scp>B</scp> virus infections

Marion Vermeulen, Charl Coleman, Josephine Mitchel, +4

Transfusion

Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk

Marion Vermeulen, Charl Coleman, Josephine Mitchel, +5

Transfusion

A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios

Jos Weusten, Harry van Drimmelen, Marion Vermeulen, +1

Transfusion

Head‐to‐head comparison of two transcription‐mediated amplification assay versions for detection of hepatitis <scp>B</scp> virus, hepatitis <scp>C</scp> virus, and human immunodeficiency virus <scp>T</scp>ype 1 in blood donors

Piotr Grabarczyk, Harry van Drimmelen, Aneta Kopacz, +9

Transfusion

Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples

Syria Laperche, C. Micha Nübling, Susan L. Stramer, +10

Transfusion

A mathematical approach to estimate the efficacy of individual‐donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections

Marion Vermeulen, Harry van Drimmelen, Charl Coleman, +3

Transfusion

Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios

Magdy El Ekiaby, Faten Moftah, Heidi Goubran, +5

Transfusion

Inclusion of human immunodeficiency virus Type 2 (HIV‐2) in a multiplex transcription‐mediated amplification assay does not affect detection of HIV‐1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study

Piotr Grabarczyk, Marco Koppelman, Fiona Boland, +8

Transfusion

Reassessment of hepatitis B virus window periods for two transcription‐mediated amplification assays using screening data of South African blood donors

Marion Vermeulen, Harry van Drimmelen, Charl Coleman, +5

Transfusion